FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282968342> ?p ?o ?g. }

• W4282968342 endingPage "5415" @default.
• W4282968342 startingPage "5415" @default.
• W4282968342 abstract "Abstract Background: Glypican-3 (GPC3) is an oncofetal tumor antigen that is an attractive target for chimeric antigen receptor (CAR) T cell therapy due to its highly restricted expression on normal tissue and high prevalence in several adult and pediatric solid tumors. Aberrant GPC3 expression is implicated in tumorigenesis, and GPC3+ cancers are characterized by a highly immunosuppressive landscape which induces exhaustion in tumor-resident T cells. We sought to assess the validity of a GPC3 antibody clone in immunohistochemistry (IHC) and then measure GPC3+ prevalence in selected solid tumors. Methods: We evaluated GPC3 transcripts in human normal and tumor tissue specimens from The Cancer Genome Atlas (TCGA) and the Genome-Tissue Expression Project. GPC3 IHC was performed on formalin fixed paraffin embedded tumor tissues: hepatocellular (HCC), squamous cell lung (SCC), colorectal (CRC), serous ovarian (OC), Merkel cell carcinomas (MCC) and liposarcoma (LS) using antibody clone GC33 and scored using H-score (range 0-300), with appropriate positive and negative controls. Accuracy and precision of GPC3 antibody clone GC33 were tested in GPC3+ high prevalence tumor types compared to a validated anti-GPC3 clone (1G12). GPC3+ cutoff was set as H-score ≥ 30 (GC33) compared to &gt;20 (1G12). The prevalence of GPC3 expression measured by IHC was also used to calculate the theoretical mRNA cutoff value from the TCGA data for GPC3+ indications represented in the database. Results: GPC3 mRNA was expressed at low levels predominantly in lung, adipose, tibial nerve, kidney and breast. GPC3 IHC of normal tissue showed predominantly faint, cytoplasmic staining in a few tissues including heart, kidney and stomach and no expression in lung or breast. HCC, SCC, LS, CRC, and OC showed high and varying levels of GPC3 mRNA expression in TCGA samples. The theoretical mRNA expression cutoff value based on IHC were HCC=1396 RSEM, SCC= 2675 RSEM, Sarcoma= 4126 RSEM; and OC 4486 RSEM; respectively. A cutoff for CRC could not be determined because the prevalence of GPC3 by IHC was &lt;10%. GPC3 IHC using GC33 showed a higher prevalence of positive cases in myxoid/round cell LS (MRCLS) relative to other LS subtypes (15/45 vs. 8/75). HCC (n=110), SCC (n=73), MRCLS (n=45), and MCC (n=20) had a prevalence of 69%, 33%, 33%, and 70%; respectively. However, &lt;10% of CRC (n=80) or OC (n=31) were GPC3+. GPC3 IHC assay using clone GC33 was fully validated for use as a lab-developed test by assessing accuracy, sensitivity, specificity, and precision in SCC, HCC, MCC and LS specimens. Conclusions: GPC3 has a high prevalence in selected tumors with low level expression in some normal tissues, making it an attractive target for CAR T cell therapy. The GC33 clone performs similarly to 1G12 and could be used for IHC screening for CAR T cell therapy. MRCLS has higher prevalence of GPC3+ expression relative to other LS subtypes. Citation Format: Glen J. Weiss, Amy Jensen-Smith, Sujatha Muralidharan. Glypican-3 immunohistochemistry precision, validation, and prevalence in selected solid tumors to identify target populations for CAR T cell therapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5415." @default.
• W4282968342 created "2022-06-17" @default.
• W4282968342 creator A5070055257 @default.
• W4282968342 creator A5080669646 @default.
• W4282968342 creator A5085641237 @default.
• W4282968342 date "2022-06-15" @default.
• W4282968342 modified "2023-09-30" @default.
• W4282968342 title "Abstract 5415: Glypican-3 immunohistochemistry precision, validation, and prevalence in selected solid tumors to identify target populations for CAR T cell therapy" @default.
• W4282968342 doi "https://doi.org/10.1158/1538-7445.am2022-5415" @default.
• W4282968342 hasPublicationYear "2022" @default.
• W4282968342 type Work @default.
• W4282968342 citedByCount "0" @default.
• W4282968342 crossrefType "journal-article" @default.
• W4282968342 hasAuthorship W4282968342A5070055257 @default.
• W4282968342 hasAuthorship W4282968342A5080669646 @default.
• W4282968342 hasAuthorship W4282968342A5085641237 @default.
• W4282968342 hasConcept C121608353 @default.
• W4282968342 hasConcept C126322002 @default.
• W4282968342 hasConcept C142724271 @default.
• W4282968342 hasConcept C150173356 @default.
• W4282968342 hasConcept C204232928 @default.
• W4282968342 hasConcept C2779742787 @default.
• W4282968342 hasConcept C71924100 @default.
• W4282968342 hasConcept C86803240 @default.
• W4282968342 hasConceptScore W4282968342C121608353 @default.
• W4282968342 hasConceptScore W4282968342C126322002 @default.
• W4282968342 hasConceptScore W4282968342C142724271 @default.
• W4282968342 hasConceptScore W4282968342C150173356 @default.
• W4282968342 hasConceptScore W4282968342C204232928 @default.
• W4282968342 hasConceptScore W4282968342C2779742787 @default.
• W4282968342 hasConceptScore W4282968342C71924100 @default.
• W4282968342 hasConceptScore W4282968342C86803240 @default.
• W4282968342 hasIssue "12_Supplement" @default.
• W4282968342 hasLocation W42829683421 @default.
• W4282968342 hasOpenAccess W4282968342 @default.
• W4282968342 hasPrimaryLocation W42829683421 @default.
• W4282968342 hasRelatedWork W1696461650 @default.
• W4282968342 hasRelatedWork W1996793462 @default.
• W4282968342 hasRelatedWork W2034986374 @default.
• W4282968342 hasRelatedWork W2045400464 @default.
• W4282968342 hasRelatedWork W2065416233 @default.
• W4282968342 hasRelatedWork W2077263403 @default.
• W4282968342 hasRelatedWork W2386104765 @default.
• W4282968342 hasRelatedWork W2414756252 @default.
• W4282968342 hasRelatedWork W3165179985 @default.
• W4282968342 hasRelatedWork W3216223813 @default.
• W4282968342 hasVolume "82" @default.
• W4282968342 isParatext "false" @default.
• W4282968342 isRetracted "false" @default.
• W4282968342 workType "article" @default.